ClinicalTrials.gov - Information on Clinical Trials and Human Research Studies: Browse: Cancer Research Campaign Clinical Trials Centre


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

Browse : By Sponsor : University/Organization : Cancer Research Campaign Clinical Trials Centre

Include trials that are no longer recruiting patients.

22 studies were found.
1. Recruiting Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer
Condition: stage I breast cancer
2. No longer recruiting Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
3. No longer recruiting Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
Conditions: contiguous stage II diffuse small lymphocytic/marginal zone lymphoma; stage I diffuse small lymphocytic/marginal zone lymphoma
4. Completed Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer
Conditions: recurrent ovarian epithelial cancer; stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; ...
5. No longer recruiting Bryostatin 1 In Treating Patients With Progressive Kidney Cancer
Conditions: stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer; stage I renal cell cancer; stage II renal cell cancer
6. No longer recruiting Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer
Conditions: stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; ...
7. No longer recruiting Chemotherapy in Treating Patients With Solid Tumors
Condition: unspecified adult solid tumor, protocol specific
8. No longer recruiting Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma
Condition: Lymphoma
9. Recruiting Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery
Conditions: stage I breast cancer; stage II breast cancer
10. Recruiting Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer
11. No longer recruiting Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors
Condition: unspecified adult solid tumor, protocol specific
12. No longer recruiting Doxorubicin in Treating Women With Advanced Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer
13. Recruiting Doxorubicin With or Without Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
Conditions: advanced adult primary liver cancer; adult primary hepatocellular carcinoma
14. Recruiting Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer
15. No longer recruiting Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma
Conditions: Cancer; Infection
16. No longer recruiting PNU 166148 in Treating Patients With Metastatic Solid Tumors
Condition: unspecified adult solid tumor, protocol specific
17. No longer recruiting Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
Conditions: Oropharyngeal Cancer; Head and Neck Cancer; lip and oral cavity cancer
18. Recruiting Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
Conditions: stage II bladder cancer; stage III bladder cancer; transitional cell carcinoma of the bladder; squamous cell carcinoma of the bladder; ...
19. No longer recruiting Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer
Conditions: stage II colon cancer; stage III colon cancer; stage II rectal cancer; stage III rectal cancer
20. Recruiting Tamoxifen in Treating Women With Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer
21. No longer recruiting Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
Conditions: stage II breast cancer; stage I breast cancer; stage IIIA breast cancer
22. Recruiting Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters
Condition: Thromboembolism

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services

1.	Recruiting	Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer Condition: stage I breast cancer
2.	No longer recruiting	Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
3.	No longer recruiting	Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma Conditions: contiguous stage II diffuse small lymphocytic/marginal zone lymphoma; stage I diffuse small lymphocytic/marginal zone lymphoma
4.	Completed	Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer Conditions: recurrent ovarian epithelial cancer; stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; ...
5.	No longer recruiting	Bryostatin 1 In Treating Patients With Progressive Kidney Cancer Conditions: stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer; stage I renal cell cancer; stage II renal cell cancer
6.	No longer recruiting	Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer Conditions: stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; ...
7.	No longer recruiting	Chemotherapy in Treating Patients With Solid Tumors Condition: unspecified adult solid tumor, protocol specific
8.	No longer recruiting	Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma Condition: Lymphoma
9.	Recruiting	Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery Conditions: stage I breast cancer; stage II breast cancer
10.	Recruiting	Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer Conditions: stage I breast cancer; stage II breast cancer
11.	No longer recruiting	Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors Condition: unspecified adult solid tumor, protocol specific
12.	No longer recruiting	Doxorubicin in Treating Women With Advanced Breast Cancer Conditions: stage IV breast cancer; recurrent breast cancer
13.	Recruiting	Doxorubicin With or Without Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer) Conditions: advanced adult primary liver cancer; adult primary hepatocellular carcinoma
14.	Recruiting	Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer Conditions: stage I breast cancer; stage II breast cancer
15.	No longer recruiting	Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma Conditions: Cancer; Infection
16.	No longer recruiting	PNU 166148 in Treating Patients With Metastatic Solid Tumors Condition: unspecified adult solid tumor, protocol specific
17.	No longer recruiting	Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer Conditions: Oropharyngeal Cancer; Head and Neck Cancer; lip and oral cavity cancer
18.	Recruiting	Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer Conditions: stage II bladder cancer; stage III bladder cancer; transitional cell carcinoma of the bladder; squamous cell carcinoma of the bladder; ...
19.	No longer recruiting	Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer Conditions: stage II colon cancer; stage III colon cancer; stage II rectal cancer; stage III rectal cancer
20.	Recruiting	Tamoxifen in Treating Women With Breast Cancer Conditions: stage I breast cancer; stage II breast cancer
21.	No longer recruiting	Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer Conditions: stage II breast cancer; stage I breast cancer; stage IIIA breast cancer
22.	Recruiting	Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters Condition: Thromboembolism